Business Standard

Top headlines: Serum halts vaccine trial; steel companies reorient strategy

From Silver Lake buying stake in Reliance Retail to Serum Institute halting trial of Oxford vaccine, here are the top headline of the day

Coronavirus, vaccine, covid
Premium

The British-Swedish drug major had decided to stop trials after a participant fell sick with an unexplained illness.

BS Web Team New Delhi
We are nowhere close to saturation in edtech space: Byju's founder & CEO

Even during the pandemic, the Bengaluru-based Byju's has received investments from celebrated investors like Mary Meeker and Yuri Milner, and now from US private equity firm Silver Lake, taking its valuation close to $11 billion. Founder and CEO BYJU Raveendran tells Bibhu Ranjan Mishra in an interview what all this means for the company. Read More
 
Covid-19: Serum Institute to halt trial of Oxford vaccine after DCGI notice

In a major turn of events, the Indian drug regulator on Wednesday issued a show cause notice

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in